Parkview Health, a 10-hospital system based in Fort Wayne, Ind., won the Top Supply Chain Projects Award from Supply & Demand Chain Executive for synchronizing its pharmacy and supply chain processes.
Astellas Pharma US will stop distributing Xtandi, a prostate cancer drug that costs about $160,000 each year, to 340B contract pharmacies on Sept. 1, according to a letter obtained by 340B Health.
Johnstown (Colo.) Heights Behavioral Health has been hit with an immediate jeopardy citation, the second one it has been issued since November 2022, ABC affiliate KMGH reported July 4.
The FDA has rejected Amneal Pharmaceuticals’ new drug application for IPX203, which the company hoped would be approved for treatment of Parkinson’s disease.